Position
Squarepoint Ops LLC in Arcutis Biotherapeutics, Inc.
Back to the book · All holders of ARQT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$2.5M$29.04 → $23.56
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 455.9K | $13.2M | — | — | — | 0.0% |
| Q1 2026 | 1.1M | $26M | $23.56 | −$2.5M | $15.3M | 0.0% |